Literature DB >> 25571984

Rational targeting of active-site tyrosine residues using sulfonyl fluoride probes.

Erik C Hett1,2, Hua Xu1,2, Kieran F Geoghegan1,2, Ariamala Gopalsamy1,2, Robert E Kyne1,2, Carol A Menard1,2, Arjun Narayanan1,2, Mihir D Parikh1,2, Shenping Liu1,2, Lee Roberts1,2, Ralph P Robinson1,2, Michael A Tones1,2, Lyn H Jones1,2.   

Abstract

This work describes the first rational targeting of tyrosine residues in a protein binding site by small-molecule covalent probes. Specific tyrosine residues in the active site of the mRNA-decapping scavenger enzyme DcpS were modified using reactive sulfonyl fluoride covalent inhibitors. Structure-based molecular design was used to create an alkyne-tagged probe bearing the sulfonyl fluoride warhead, thus enabling the efficient capture of the protein from a complex proteome. Use of the probe in competition experiments with a diaminoquinazoline DcpS inhibitor permitted the quantification of intracellular target occupancy. As a result, diaminoquinazoline upregulators of survival motor neuron protein that are used for the treatment of spinal muscular atrophy were confirmed as inhibitors of DcpS in human primary cells. This work illustrates the utility of sulfonyl fluoride probes designed to react with specific tyrosine residues of a protein and augments the chemical biology toolkit by these probes uses in target validation and molecular pharmacology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25571984     DOI: 10.1021/cb5009475

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  36 in total

1.  Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer Interface.

Authors:  Mingxing Teng; Scott B Ficarro; Hojong Yoon; Jianwei Che; Jing Zhou; Eric S Fischer; Jarrod A Marto; Tinghu Zhang; Nathanael S Gray
Journal:  ACS Med Chem Lett       Date:  2020-04-03       Impact factor: 4.345

2.  Know your target, know your molecule.

Authors:  Mark E Bunnage; Adam M Gilbert; Lyn H Jones; Erik C Hett
Journal:  Nat Chem Biol       Date:  2015-06       Impact factor: 15.040

3.  Development of inverse electron demand Diels-Alder ligation and TR-FRET assays for the determination of ligand-protein target occupancy in live cells.

Authors:  Jasmina Marjanovic; Aleksandra Baranczak; Violeta Marin; Henning Stockmann; Paul L Richardson; Anil Vasudevan
Journal:  Medchemcomm       Date:  2017-02-21       Impact factor: 3.597

4.  Developing bioorthogonal probes to span a spectrum of reactivities.

Authors:  Sean S Nguyen; Jennifer A Prescher
Journal:  Nat Rev Chem       Date:  2020-07-21       Impact factor: 34.035

5.  SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase.

Authors:  Qinheng Zheng; Jordan L Woehl; Seiya Kitamura; Diogo Santos-Martins; Christopher J Smedley; Gencheng Li; Stefano Forli; John E Moses; Dennis W Wolan; K Barry Sharpless
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

Review 6.  Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation.

Authors:  Tinghu Zhang; John M Hatcher; Mingxing Teng; Nathanael S Gray; Milka Kostic
Journal:  Cell Chem Biol       Date:  2019-10-17       Impact factor: 8.116

7.  Emerging Utility of Fluorosulfate Chemical Probes.

Authors:  Lyn H Jones
Journal:  ACS Med Chem Lett       Date:  2018-06-27       Impact factor: 4.345

8.  Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue.

Authors:  Wentao Chen; Jiajia Dong; Lars Plate; David E Mortenson; Gabriel J Brighty; Suhua Li; Yu Liu; Andrea Galmozzi; Peter S Lee; Jonathan J Hulce; Benjamin F Cravatt; Enrique Saez; Evan T Powers; Ian A Wilson; K Barry Sharpless; Jeffery W Kelly
Journal:  J Am Chem Soc       Date:  2016-06-02       Impact factor: 15.419

9.  Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases.

Authors:  Khuchtumur Bum-Erdene; Degang Liu; Giovanni Gonzalez-Gutierrez; Mona K Ghozayel; David Xu; Samy O Meroueh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

10.  The long form of pVHL is artifactually modified by serine protease inhibitor AEBSF.

Authors:  Daniel Tarade; Shelley He; Jonathan St-Germain; Avi Petroff; Anya Murphy; Brian Raught; Michael Ohh
Journal:  Protein Sci       Date:  2020-06-25       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.